Rozprawy doktorskie na temat „Phosphoribosyltransferase”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 47 najlepszych rozpraw doktorskich naukowych na temat „Phosphoribosyltransferase”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj rozprawy doktorskie z różnych dziedzin i twórz odpowiednie bibliografie.
Catton, Gemma R. "Mechanistic studies on quinolinate phosphoribosyltransferase /". St Andrews, 2007. http://hdl.handle.net/10023/485.
Pełny tekst źródłaCatton, Gemma Rachel. "Mechanistic studies on quinolinate phosphoribosyltransferase". Thesis, University of St Andrews, 2008. http://hdl.handle.net/10023/485.
Pełny tekst źródłaMarinaki, Anthony Marin. "The biochemical and molecular basis of Hypoxanthine-guanine phosphoribosyltransferase deficiency". Doctoral thesis, University of Cape Town, 1996. http://hdl.handle.net/11427/26969.
Pełny tekst źródłaMurungi, Edwin Kimathi. "Purification and characterisation of plasmodium falciparum Hypoxanthine phosphoribosyltransferase". Thesis, University of the Western Cape, 2007. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_9199_1257245819.
Pełny tekst źródłaMalaria remains the most important parasitic disease worldwide. It is estimated that over 500 million infections and more that 2.7 million deaths arising from malaria occur each year. Most (90%) of the infections occur in Africa with the most affected groups being children of less than five years of age and women. this dire situation is exacerbated by the emrggence of drug resistant strains of Plasmodium falciparum. The work reported in this thesis focuses on improving the purification of PfHPRT by investigating the characteristics of anion exchange DE-52 chromatography (the first stage of purification), developing an HPLC gel filtration method for examining the quaternary structure of the protein and possible end stage purification, and initialcrystalization trials. a homology model of the open, unligaded PfHPRT is constructed using the atoomic structures of human, T.ccruz and STryphimurium HPRT as templates.
Ford, Barry Noel. "Structure-function relationships in Chinese hamster adenine phosphoribosyltransferase". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp02/NQ34263.pdf.
Pełny tekst źródłaShahabuddin, Mohammed. "Molecular studies on the hypoxanthine phosphoribosyltransferase of Plasmodium falciparum". Thesis, University of Edinburgh, 1990. http://hdl.handle.net/1842/14382.
Pełny tekst źródłaMittelstädt, Gerd Horst. "Allosteric regulation of the adenosine triphosphate phosphoribosyltransferase from campylobacter jejuni". Thesis, University of Canterbury. Chemistry, 2015. http://hdl.handle.net/10092/10799.
Pełny tekst źródłaEvans, Laura. "Investigating the role of nicotinamide phosphoribosyltransferase (NAMPT) in cartilage catabolism". Thesis, Cardiff University, 2013. http://orca.cf.ac.uk/58335/.
Pełny tekst źródłaDuckworth, Megan Jane Medical Sciences Faculty of Medicine UNSW. "Characterisation of the xanthineguanine phosphoribosyltransferase of helicobacter pylori as a potential therapeutic target". Publisher:University of New South Wales. Medical Sciences, 2008. http://handle.unsw.edu.au/1959.4/43418.
Pełny tekst źródłaPhehane, Vuyisile Ntosi. "The expression and drug targeting of parasitic hypoxanthine-guanine phosphoribosyltransferase (HGPRT)". Doctoral thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/2701.
Pełny tekst źródłaWe have expressed and purified human, two forms of P. falciparum, and Toxoplasma gondii hypoxanthine-guanine phosphoribosyltransferase (HPRT) in E. coli using the pET expression system. The cDNA encoding the ORF of HPRT was amplified by PCR and transformed into E. coli cells using standard methods. Expression was induced by IPTG and reached about 13% of the total cell protein for all four proteins. The HPRTs were purified by nickel affinity chromatography most of the expressed protein could be isolated from the crude supernatant fraction in a soluble form. Human HPRT was active, with activity levels in the region of 38 umoles GMP min⁻¹ mg⁻¹ at 37 ⁰C, which is comparable to published literature values.
Sintra, Pisco João. "Studies on the mechanism of allosteric regulation of M. tuberculosis ATP-phosphoribosyltransferase". Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10046004/.
Pełny tekst źródłaColgin, Lorel Melanie. "Spontaneous mutations in aging human renal epithelia in vivo /". Thesis, Connect to this title online; UW restricted, 1997. http://hdl.handle.net/1773/6318.
Pełny tekst źródłaJunior, Alécio Antonio Pimenta. "Estudos estruturais e correlação com a síndrome urolitíase de mutantes da adenina fosforribosiltransferase humana". Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-29082011-095840/.
Pełny tekst źródła2,8-DHA Urolithiasis is a disease resulting from an inherited disorder that leads to deficiency of APRT, an enzyme of the PRTases group. So far, 18 mutations were found in patients, 7 of which are missense. This work is dedicated to the functional and structural study of these 7 mutations and the deletion ΔF173. Mutants constructions D65V, L110P, M136T, R67Q, R89Q, I112F and F173G were obtained in the vector pET-29a (+) and cloned in E. coli. The expression and purification protocols were established and the enzymes were obtained after 1 chromatographic step using the CHTTM Hydroxyapatite Ceramics column in the required purity. The only exception was the mutant I112F that resulted insoluble during expression. A coupled kinetic assay using PPi detection kit was standardized and allowed the kinetic characterization of native hAPRT and its mutants. The mutants had an efficiency loss of an order of magnitude, with the exception of F173G, whose values were comparable to those of native hAPRT. Crystallization trials were performed for all mutants and resulted in crystals for mutants F173G, R67Q and R89Q. These crystals were collected on Macromolecules Crystallography 2 line at LNLS. The datasets are being analyzed and the structures are in the final stages of refinement.
Nelson, Aileen A. "The significance of adenine phosphoribosyltransferase for DNA excision repair processes in friend erythroleukaemia cells". Thesis, University of Ulster, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241676.
Pełny tekst źródłaMbewe, Boniface. "Cloning, expression, purification and drug targeting of Plasmodium falciparum hypoxanthine guanine xanthine phosphoribosyltransferase (HGXPRT)". Doctoral thesis, University of Cape Town, 2005. http://hdl.handle.net/11427/2696.
Pełny tekst źródłaThe research concerns sub-cloning the gene for HGXPRT from Plasmodium falciparum from a vector with a His-tag facility to one without, expression of the protein in E. coli, and purification. On an analytical scale (40 ml culture), a purification procedure was developed that involves extraction of contaminating proteins by anion exchange chromatography (HGXPRT does not bind under the conditions used), followed by Reactive Red 120 agarose affinity chromatography.
GIMBERT, LUC. "A propos d'un nouveau cas de lithiase de 2,8 dihydroxyadenine par deficit complet en adenine phosphoribosyltransferase et de son traitement par une dissolution in situ". Aix-Marseille 2, 1989. http://www.theses.fr/1989AIX20401.
Pełny tekst źródłaLorenz, Veronika. "Komplexe Veränderungen in der Genexpression der Ecto-Nukleosid-5-Triphosphat-Diphosphohydrolase bei Hypoxanthin-Phosphoribosyltransferase-Defizienz". kostenfrei, 2008. http://www.opus-bayern.de/uni-regensburg/volltexte/2009/1207/.
Pełny tekst źródłaCookson, Tammie Violet Marie. "Probing the active site of anthranilate phosphoribosyltransferase from Mycobacterium tuberculosis to facilitate novel drug development". Thesis, University of Canterbury. Chemistry, 2013. http://hdl.handle.net/10092/9049.
Pełny tekst źródłaElangovan, Venkateswaran Ramamoorthi, Sara M. Camp, Gabriel T. Kelly, Ankit A. Desai, Djanybek Adyshev, Xiaoguang Sun, Stephen M. Black, Ting Wang i Joe G. N. Garcia. "Endotoxin- and Mechanical Stress–Induced Epigenetic Changes in the Regulation of the Nicotinamide Phosphoribosyltransferase Promoter". UNIV CHICAGO PRESS, 2016. http://hdl.handle.net/10150/622492.
Pełny tekst źródłaGaillard, Catherine. "Contribution a l'etude du role des genes d'adenine phosphoribosyltransferase dans le metabolisme des cytokinines chez les plantes". Paris 11, 1997. http://www.theses.fr/1997PA112034.
Pełny tekst źródłaLoCoco, Peter M. "Pharmacological Stimulation of Nicotinamide Phosphoribosyltransferase with P7c3-A20 as a Protective Strategy for Paclitaxel-Induced Peripheral Neuropathy". Thesis, The University of Texas Health Science Center at San Antonio, 2017. http://pqdtopen.proquest.com/#viewpdf?dispub=10273903.
Pełny tekst źródłaImprovements in anticancer pharmacotherapy over the past 40 years have led to a steady increase in the number of cancer survivors worldwide. The clinical effectiveness of anticancer agents like the microtubule-stabilizing agent, paclitaxel, ultimately led to their adoption into standard of care regimens for most cancers. What makes these drugs so effective is how they bind to their respective targets to disrupt fundamental cellular processes. For example, by binding to β-tubulin, paclitaxel induces polymerization and stabilization of cellular microtubules, leading to impairments in cellular functions like mitosis and intracellular transport. While an ingenious approach to kill cancer cells, microtubules are ubiquitous in all cell types. Consequently, paclitaxel has a burdensome side effect profile due to its effects on noncancerous cells. The most prevalent nonhematologic side effect is chemotherapy-induced peripheral neuropathy, which arises due to paclitaxel-induced damage to peripheral afferent sensory neurons. Cancer patients with peripheral neuropathy often develop debilitating neuropathic pain and numbness that diminish everyday quality of life. Symptoms intensify as treatment progresses and can persist for months and years beyond treatment. There is no effective treatment or prevention for chemotherapy-induced peripheral neuropathy. Instead, patients must dose de-escalate or discontinue life-saving chemotherapy, which subsequently worsens cancer prognosis. Thus, there is a compelling need to identify novel therapeutic options to prevent or treat chemotherapy-induced peripheral neuropathy so to improve both anticancer treatment and patient quality of life. The goal of this dissertation is to evaluate the neuroprotective efficacy of a first-in-class stimulator of nicotinamide phosphoribosyltransferase, P7C3-A20, against paclitaxel-induced peripheral neurotoxicity. Nicotinamide phosphoribosyltransferase is the rate-limiting enzyme in the salvage pathway for nicotinamide adenine dinucleotide, an indispensable redox biomolecule that drives energy production. We first developed an aggressive model of paclitaxel-induced peripheral neuropathy in adult male rats. Treatment with a near maximally-tolerated dose of paclitaxel produced significant, but recoverable weight loss and leukopenia. Paclitaxel-treated rats exhibited differentially altered nociceptive thresholds to noxious stimuli, including the development of persistent allodynia to mechanical and cold stimulation as well as transient hyposensitivity to heat stimulation. Toxicity associated with paclitaxel treatment required that 25% of the rats be removed from the study. Histological analysis determined that paclitaxel triggered degeneration of intraepidermal nerve fibers and up-regulated expression of activating transcription factor 3 in nuclei of neuron cell bodies residing in the lumbar dorsal root ganglia. Remarkably, daily treatment with P7C3-A20 prevented mechanical allodynia and heat hypoalgesia, and reduced the cold allodynia associated with paclitaxel treatment. P7C3-A20 also prevented intraepidermal nerve fiber degeneration and partially decreased activating transcription factor 3 expression in lumbar dorsal root ganglia neurons. A randomized, double-blind trial determined that P7C3-A20, and another analogue, P7C3-S321, dose-dependently decreased paclitaxel-induced neuropathic pain and intraepidermal nerve fiber loss. Furthermore, P7C3-A20 improved indices of general health and prevented premature death that normally arose because of overt toxicity caused by paclitaxel. P7C3-A20 displayed superior neuroprotective efficacy, while an inhibitor of poly(adenosine diphosphate-ribose) polymerase was completely ineffective. P7C3-A20 stimulated nicotinamide adenine dinucleotide production in vitro following induction of damage with either hydrogen peroxide or paclitaxel, but not under normal conditions. Additionally, P7C3-A20 in vivo stimulated nicotinamide adenine dinucleotide recovery in the hindpaw and sciatic nerve of rats treated with paclitaxel. FK866 blocked P7C3-A20-mediated nicotinamide adenine dinucleotide production in vitro and the neuroprotective effects on peripheral nociceptive neurons in vivo. Although treatment with either nicotinamide or a subthreshold dose of P7C3-A20 alone was ineffective, the combination produced neuroprotection against paclitaxel that was equivalent to that of a maximal dose of P7C3-A20. We also investigated the effects of P7C3-A20 on cancer cell proliferation and on the anticancer efficacy of paclitaxel. Only MDA-MB-231 breast cancer cells demonstrated a slight increase in proliferation by P7C3-A20, but enhanced growth of implanted MDA-MB-231 tumor xenografts was not observed. Furthermore, P7C3-A20 did not diminish the antiproliferative effects of paclitaxel, despite preventing the development of mechanical allodynia in the tumored mice. In conclusion, these studies discovered robust neuroprotective efficacy of P7C3-A20 against paclitaxel -induced peripheral neurotoxicity, likely through the enhancement of nicotinamide phosphoribosyltransferase-mediated recovery of nicotinamide adenine dinucleotide. Based on these results, clinical investigation of P7C3-A20 as a potential treatment option for chemotherapy-induced peripheral neuropathy may be warranted.
Hyland, Paula Lisa. "Sequence analysis of the adenine phosphoribosyltransferase gene locus in wild-type and thymidine kinase-deficient friend erythroleukaemia cells". Thesis, University of Ulster, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.390158.
Pełny tekst źródłaCaldas, Victor Emanoel Armini. "Adenina fosforibosiltransferase de Schistosoma mansoni: proposta de detalhamento do mecanismo catalítico por dinâmica molecular". Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-19102011-141742/.
Pełny tekst źródłaThe Adenine Phoshoribosyltransferase (APRT E.C.2.4.2.7) belongs to the Phosphoribosyltransferase enzyme family (PRTase) of type I which catalyzes the reversible conversion of adenine and 5-phospho-α-D-ribose-1-diphosphate (PRPP) in diphosphate and adenosine monophosphate, an important source of this compound for the cell. APRT is involved in the purine salvage pathway, the only way that Schistosoma mansoni has to supply its purine demands. This work shows the isolation, cloning, heterologous expression and the purification of APRT from S. mansoni in order to establish its physical chemical and kinetics parameters. Since crystallographic structure was not obtained, we built homology models to perform molecular dynamics experiments and conformational evaluation via tCONCOORD. The human APRT structure was used as control in the simulation experiments. The computational and molecular biology data were compared for consistency and the detailed analysis of the former allowed us to improve experimental manipulation of APRT. The molecular dynamics experiments showed the opening of the loops of the catalytic binding site and the key function of rotamers. Finally, we were able to suggest that a water molecule may catch the proton of adenine N9. Both observations improve the current view of APRT catalytic mechanism.
Livingstone, Emma Kathrine. "Allosteric Regulation of the First Enzyme in Histidine Biosynthesis". Thesis, University of Canterbury. Chemistry, 2015. http://hdl.handle.net/10092/10470.
Pełny tekst źródłaDantas, Deyse de Souza. "Caracterização estrutural e bioquimica da hipoxantina-guanina-xantina fosforribosiltransferase". [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314756.
Pełny tekst źródłaTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-11T15:38:56Z (GMT). No. of bitstreams: 1 Dantas_DeysedeSouza_D.pdf: 4937353 bytes, checksum: 5c9b26f6ef8ed34e974ca6c8bb0708f2 (MD5) Previous issue date: 2008
Resumo: Os genes que codificam para a 6-oxopurina fosforribosiltransferase (HPRT, EC2.4.2.8) dos organismos Pyrococcus horikoshii e Schistosoma mansoni foram clonados em vetores de expressão. As proteínas foram expressas e purificadas em larga escala no sistema de expressão de Escherichia coli. Estudos cinéticos mostraram que a enzima de P. horikoshii é capaz de usar hipoxantina, guanina e xantina. Os dois primeiros substratos apresentam uma eficiência catalítica semelhante. A xantina apresenta um valor menor (ao redor de 20 vezes mais baixo), mas a constante catalítica é comparável com a da hipoxantina. A proteína não foi capaz de se ligar a GMP-agarose, mas sim pode ligar o outro substrato da reação reversa, pirofosfato inorgânico, com baixa afinidade (Kd = 4,7 ± 0,1 mM). Os dados de espalhamento dinâmico de luz, gel filtração e espalhamento de raios X a baixo ângulo mostram que esta proteína é um homohexâmero em solução. Este hexâmero é compacto e resistente à ação limitada de enzimas proteolíticas. Estudos de estabilidade frente a agentes químicos mostraram que a proteína é bastante estável resistindo os efeitos da uréia sem desenovelar completamente com a maior concentração do agente (8,0 M). Os dados obtidos com cloreto de guanidina mostraram que a proteína possui, no mínimo, um estado intermediário de desnaturação, como mostram os diferentes perfis obtidos com as diferentes técnicas usadas nos estudos de desnaturação. Os dados preliminares obtidos com a HPRT de S. mansoni mostraram que, na presença da cauda de histidinas, a proteína está presente como um octâmero alongado. Mas, muito provavelmente ela deve ser um tetrâmero. A presença de caudas fusionadas nas proteínas recombinantes pode afetar a estrutura e função das proteínas
Abstract: The genes that code for the 6-oxopurine phosphoribosyltransferase (HPRT, EC2.4.2.8) from the organisms Pyrococcus horikoshii and Schistosoma mansoni were cloned in expression vectors. The proteins were expressed and purified in large scale in the de Escherichia coli expression system. Kinetic studies showed that the enzyme from P. horikoshii is able to use hypoxanthine, guanine and xanthine. The first two substrates show a similar catalytic efficiency. Xanthine show a lower value (around 20 times), but the catalytic constant is comparable to that of hypoxanthine. The protein was unable to bind to GMP-agarose, but was able to bind the other substrate of the reverse reaction, inorganic pyrophosphate, with low affinity (Kd = 4.7 ± 0.1 mM). Dynamic light scattering, gel filtration and small angle X-ray scattering data show that the protein is a homohexamer in solution. This hexamer is compact and resistant to the limited action of proteolytic enzymes. Stability studies with chemical agents showed that the protein is very stable being able to stand the effects of urea without unfolding completely at the highest agent concentration (8.0 M). Data obtained with guanidine hydrochloride showed that the protein presents, at least, one unfolding intermediate state, as can be seen with the different profiles obtained with different techniques used in the unfolding studies. Preliminary data obtained from HPRT from S. mansoni showed that in the presence of the histidine tag, is present as a long octamer. But, most likely it should be a tetramer. The presence of histidine tag fused to the recombinant proteins could affect the structure and function of proteins
Doutorado
Bioquimica
Doutor em Biologia Funcional e Molecular
Lecomte, Isabelle. "Métabolisme purique chez le pécher. Recherche d'enzymes marqueurs de potentialités de croissance des bourgeons : étude de l'adénine phosphoribosyltransferase et de l'adénosine nucleosidase". Clermont-Ferrand 2, 1999. http://www.theses.fr/1999CLF22165.
Pełny tekst źródłaGrant, Donna. "Mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene in T lymphocytes from arthritis patients and in human B lymphoid cell lines exposed to nitric oxide-donating drugs". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape8/PQDD_0001/MQ46576.pdf.
Pełny tekst źródłaKallies, Mathias Sebastian [Verfasser], i George [Akademischer Betreuer] Iliakis. "The effect of high linear energy transfer ionizing radiation on mutation and reversion events at the hypoxanthin-guanin-phosphoribosyltransferase locus / Mathias Sebastian Kallies ; Betreuer: George Iliakis". Duisburg, 2017. http://d-nb.info/1133478794/34.
Pełny tekst źródłaPetitgas, Céline. "Etude des mécanismes pathogéniques de la maladie de Lesch-Nyhan en relation avec le système dopaminergique chez un organisme modèle, Drosophila melanogaster". Thesis, Paris Sciences et Lettres (ComUE), 2019. http://www.theses.fr/2019PSLET049.
Pełny tekst źródłaAdenine phosphoribosyltransferase (APRT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT) are two major enzymes involved in purine recycling in mammals, an essential metabolic pathway that allows the recovery of free purine bases derived from diet or the degradation of nucleotides. The purine salvage pathway is indeed less energy costly than de novo purine synthesis and its dysfunction induces various pathologies. In particular, inherited mutations suppressing HGPRT enzyme activity are associated with Lesch-Nyhan disease (LND), a rare X-linked metabolic and neurophysiological disorder in children, characterized by hyperuricemia and severe neurobehavioural disturbances such as dystonia, spasticity and compulsive self-injury. Studies have shown that LND patients have markedly reduced dopamine levels specifically in the basal ganglia, but the mechanisms linking the lack of HPRT activity and dopaminergic neurotransmission have not been elucidated to date. In this thesis work, we have been studying the relation between purine metabolism and the dopaminergic system in a model organism, Drosophila, with the aim to find new clues about the mechanisms involved in LND. No HGPRT homologue is present in the Drosophila genome, which suggests that the APRT homologue, named Aprt, is the only purine-recycling enzyme in this organism. Our work shows that Aprt-deficient flies have defects partly comparable to those associated with HGPRT deficiency in humans, notably an increase in uric acid levels, as well as alterations in dopaminergic markers and neurobehavioural defects. Conversely, genetic disruptions of the dopaminergic system decrease the expression and activity level of Aprt. Our results therefore confirm the conservation of a physiological link between purine recycling and the dopaminergic system in Drosophila, and further indicate that this regulation requires adenosinergic signaling. This new model could therefore prove valuable to find new therapeutic targets and possibly improve the cure of this dramatic disease
Monzani, Paulo Sérgio. "Estrutura cristalográfica da enzima hipoxantina-guanina fosforibosiltransferase (HGPRT) de Leishmania tarentolae complexada com GMP". Universidade de São Paulo, 2003. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-24062008-163341/.
Pełny tekst źródłaThe aims of this work were the cloning, expression and purification of the protein HGPRT from Leishimania tarentolae, for the characterization and crystallization of the enzyme for it structural and functional study. The full-length hgprt gene was isolated from a leishmania tarentolae UC strain Lambda ZAP Express BamHI-Sal3A I genomic library. This gene was cloned in the expression vector pET29a+, and used in the transformation of the bacteria Escherichia coli BL21(DE3). This expression system presented a super-expression of the recombinant protein, which was purified by ionic change chromatography, utilizing the anionic change column POROS 20HQ. The purified protein was utilized for its characterization, including its kinetics constants (Km, Vmax e Kcat) for different substrates. The protein was found to be a dimmer in solution with pI close to 8.2. Besides, this protein was used in the crystallization assays by the steam diffusion in suspended drop technique. The obtained crystals were utilized in the x-ray diffraction studies. The data collection was performed in the Laboratório Nacional de Luz Síncroton. The X-ray diffraction data were processed utilizing the package program HKL. The crystallographic structure resolution was obtained by the molecular replacement method from the AmoRe program. For the structure refinement, the automatic refinement programs CNS and REFMAC were used, and the graphic manipulation was made through the O program. The structure of the HGPRT was resolved with 2,1 Å of resolution and final agreement factors Rwork and Rfree of 17,34% and 21,53%, respectively.
Townsend, Michelle Hannah. "The Clinical Significance of HPRT as a Diagnostic and Therapeutic Biomarker for Hematological and Solid Malignancies". Thesis, Brigham Young University, 2018. http://pqdtopen.proquest.com/#viewpdf?dispub=10846744.
Pełny tekst źródłaAn estimated 1,735,350 new cancer diagnosis and 609,640 cancer related deaths are predicted to occur in the United States in 2018. To improve patient prognosis, biomarkers are needed to identify cancer in early stages. When diagnosed at an early stage, cancer is more likely to respond to treatments and patients have a higher survival rate. Consequently, there is an ever-present need to identify biomarkers that can aid in the detection of cancer. Additionally, there is a paradigm shift in the field of cancer treatment towards immunotherapy. Traditional cancer treatments include chemotherapy, radiation, and hormone therapy and are not cancer-specific, which leads to bystander effects on the patient’s normal organs that often harm the patient and create unnecessary hardship. To alleviate this, immunotherapy utilizes a patient’s own immune cells to attack and destroy cancer cells via cancer-specific biomarkers. These biomarkers are ideally on the surface of cancer cells and absent from the patient’s normal cells to avoid healthy tissue destruction. With this new therapy, there is a recent push to find surface antigens for immunotherapy techniques.
This dissertation describes the characterization of HPRT as a diagnostic and therapeutic biomarker for the detection and possible treatment of hematological and solid malignancies. We describe the general upregulation of HPRT upon malignancy and show that this elevation in protein expression is independent of stage, which indicates that it would be useful as an early stage diagnostic companion tool. We have preliminarily linked the elevation in HPRT to a mutation in one of its prime transcription factors, p53. Specific mutation in p53 called Gain of Function mutations have shown to influence salvage pathway enzyme expression, and we have shown that mutations in p53 are relevant to the elevated levels of HPRT within several cancer types. In addition, we also found that HPRT associates significantly with the membrane of several cancer cell lines as well as patient samples. We found that HPRT has insignificant expression on normal cells, which suggests it may be useful as a targetable biomarker for immunotherapy. Throughout our analysis, we also determined that HPRT might have a role in immune regulation as an elevation of the protein correlates to the decrease of several pro-inflammatory genes involved in immune activation. The knowledge gained from the data presented in this dissertation have opened up new functions for HPRT outside of simple nucleotide production and have confirmed that HPRT has a unique role in cancer that has not been previously reported.
Montigny, Jacky de. "Ura5 et ura10, deux genes codant pour deux isoenzymes a activite omp pyrophosphorylase chez la levure saccharomyces cerevisiae : structure, expression et regulation". Strasbourg 1, 1988. http://www.theses.fr/1988STR13198.
Pełny tekst źródłaMitchell, Shaneice Renee. "Preclinical evaluation of NAMPT inhibitor KPT-9274 in Acute Myeloid Leukemia". The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1546527486477125.
Pełny tekst źródłaFattori, Ana Carolina Maragno. "Efeitos da imunização com Adenosina Quinase (AK) e Hipoxantina-Guanina Fosforibosiltransferase (HGPRT) recombinantes de Schistosoma mansoni : controle da infecção murina". Universidade Federal de São Carlos, 2016. https://repositorio.ufscar.br/handle/ufscar/7924.
Pełny tekst źródłaApproved for entry into archive by Marina Freitas (marinapf@ufscar.br) on 2016-10-20T13:38:00Z (GMT) No. of bitstreams: 1 DissACMF.pdf: 2760486 bytes, checksum: 27824647d350872bddb22f28a9206da8 (MD5)
Approved for entry into archive by Marina Freitas (marinapf@ufscar.br) on 2016-10-20T13:38:07Z (GMT) No. of bitstreams: 1 DissACMF.pdf: 2760486 bytes, checksum: 27824647d350872bddb22f28a9206da8 (MD5)
Made available in DSpace on 2016-10-20T13:38:15Z (GMT). No. of bitstreams: 1 DissACMF.pdf: 2760486 bytes, checksum: 27824647d350872bddb22f28a9206da8 (MD5) Previous issue date: 2016-02-24
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
The mansoni schistosomiasis is the most important of human helminthiasis. Despite advances in its control this disease continues to spread to new geographical areas. It currently affects more than 250 million people. However, limited options are available for and Praziquantel is the drug of choice. Various authors have been searching new drugs and vaccines to control schistosomiasis. This study aimed to evaluate the effects of a prior immunization with recombinant enzymes of Schistosoma mansoni: Adenosine Kinase (AK) and Hypoxanthine-guanine Phosphoribosyltransferase (HGPRT), which are important for parasite purine metabolism, as well as a MIX of these enzymes, and subsequent challenge with cercariae of the parasite in the control of murine infection. Female Balb/c mice were divided into 5 groups. The groups were enzyme-immunized in three doses and 15 days after the last immunization, animals were infected with S. mansoni. After infection in the 47º day egg count were carried in mice faeces and in the 48º day mice were sacrificed for evaluation of leukocyte numbers (blood and peritoneal cavity), worm burden, antibodies production, cytokines quantification and histopathological analysis of the liver of these animals. Our results strongly suggest that, immunization with a MIX originated in these animals reduction in the number of eggs in faeces by 46% when compared with the animals of the infected group. Animals of the groups immunized with AK, HGPRT and/or MIX seem to induce a reduction in the number of eosinophils in the peritoneal cavity when compared to the animals of the infected group. Concerning worm burden, the animals of the MIX group presented greater reduction (31.27%) when compared to the animals of the infected group. The animals of the immunized groups, AK, HGPRT and/or MIX were capable of producing IgG1 antibodies and IgE anti the enzymes and anti the parasite proteins. The animals of the immunized group MIX showed a slight increase in IL-4 production and observed reduction of IL-10, and in the HGPRT group induced a slight increase on IFN-γ production when in compared with the infected group. In addition, the animals of the AK group showed a decrease in the number of hepatic granulomas in tissue (44,55%) and the eggs present in liver (42,31%). Therefore, it suggests that immunization with these enzymes can contributes to schistosomiasis control, as well as it might helps to modulate experimental infection inducing reduction of physiopathology of this parasitosis.
A esquistossomose mansônica é a mais importante das helmintíases humanas. Apesar dos avanços no seu controle continua se espalhando para novas áreas geográficas. Atualmente afeta mais de 250 milhões de pessoas. Entretanto, opções limitadas estão disponíveis para o tratamento da doença e o único fármaco de escolha é o Praziquantel. Assim, vários estudos têm sido propostos para encontrar novos fármacos e vacinas para combater a esquistossomose. Dessa forma, o presente estudo teve como proposta avaliar os efeitos da imunização prévia com as enzimas recombinantes de Schistosoma mansoni Adenosina Quinase (AK) e Hipoxantina-Guanina Fosforibosiltransferase (HGPRT), que participam do metabolismo de purinas do parasito, bem como com o MIX das duas enzimas, e posterior desafio com cercárias do parasito, para o controle da infecção murina. Camundongos fêmea Balb/c foram divididos em 5 grupos. Os grupos imunizados receberam três doses das enzimas e após 15 dias da última imunização, os animais foram infectados com S. mansoni. Após a infecção, no 47° dia foi realizada a contagem de ovos nas fezes e no 48° dia foi realizada a eutanásia dos animais para avaliação de resposta leucocitária (sangue e lavado da cavidade peritoneal), carga parasitária, produção de anticorpos, quantificação de citocinas e análise histopatológica do fígado desses animais. Os resultados demonstraram que, a imunização com o MIX promoveu nesses animais redução do número de ovos nas fezes de 46% quando comparado com os animais do grupo somente infectado. Os animais dos grupos imunizados com AK, HGPRT e/ou MIX apresentaram diminuição na quantidade de eosinófilos na cavidade peritoneal quando comparados com os animais do grupo somente infectado. Em relação à carga parasitária, os animais do grupo imunizado com o MIX apresentaram maior redução (31,27%) quando comparados aos animais do grupo somente infectado. Os animais dos grupos imunizados com AK, HGPRT e/ou MIX foram capazes de produzir anticorpos IgG1 e IgE anti as enzimas e anti as proteínas do parasito. Os animais do grupo imunizado com o MIX apresentaram aumento discreto de IL-4 e foi observada redução de IL-10, e no grupo imunizado com HGPRT houve aumento discreto de IFN-γ, quando comparados com os animais do grupo somente infectado. Além disso, os animais do grupo imunizado com AK apresentaram redução do número de granulomas hepáticos (44,55%) e de ovos no fígado (42,31%), quando comparados com o grupo somente infectado. Assim, sugere-se que a imunização com essas enzimas pode contribuir para o controle da esquistossomose, bem como auxiliar na modulação da infecção experimental, induzindo redução da fisiopatologia desta parasitose.
Romanello, Larissa. "Estudos das enzimas adenosina kinase isoforma 1, hipoxantina-guanina fosforibosiltransferase isoformas 1, 2 e 3, adenilsuccinato liase, adenilsuccinato sintetase de Schistosoma mansoni". Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-27102016-102455/.
Pełny tekst źródłaSchistosoma mansoni is the parasite responsible for schistosomiasis, disease that affects about 300 million people worldwide, and does not have the purine de novo pathway, depending entirely on the purine salvage pathway to supply its demands on purines. Currently, both direct treatment and most disease control initiatives, rely on chemotherapy using a single drug, praziquantel. Concerns over the possibility of resistance developing to praziquantel, has stimulated efforts to develop new drugs for the treatment of schistosomiasis. The purine salvage pathway has been reported as a potential target for developing new drugs against schistosomiasis. Adenosine kinase (AK), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), adenylosuccinate lyase (ADSL), adenylosuccinate synthetase (ADSS) are key enzymes in this pathway. This work is part of a larger project aimed at obtaining all the structures of enzymes involved in purine salvage pathway of Schistosoma mansoni. The cDNA corresponding to the enzymes was amplified and cloned in vector pOPIN, AK isoform 1, HGPRT isoform 1 and ADSL were expressed in E. coli Lemo 21 (DE3) and HGPRT isoform 3 in E. coli B834(DE3); purified in cobalt agarose column, concentrated and crystallized in several conditions of the Morpheus (Molecular Dimensions) crystallization kit at the Oxford Protein Production Facility (OPPF) in Harwell UK. The data collection by xray diffraction were performed at Diamond Light Source UK. Two ADSL structures were obtained, ADSL in complex with AMP at 2.36Å resolution and ADSL Apo form at 2.14Å The analysis revealed a tetrameric structure highly conserved between ADSLs, and this oligomerization state is required since residues three of the four subunits comprise the active site. Despite the active site being highly conserved between human ADSL and SmADSL, the dimeric interface of these enzymes it has been shown sufficiently distinct, which may represent a potential target for the development of an inhibitor. The ADSL enzymatic activity assay showed an endothermic reaction, indicating the contribution of the entropy related to the large quantity of water molecules present in the active site is important for the reaction kinetics. After several optimization experiments of HGPRT1 crystals and about 200 crystals tested was obtained a structure in complex with IMP at 2.8Å resolution. The structure analysis revealed a tetrameric structure. Despite the subunits do not share the active site, this oligomerization state is required, since residues that make up the active site are also involved in interactions in dimeric interface, guiding the invariable residue Arg206 toward the active site. Four mutations were identified in the region of the active site between SmHGPRT and human HGPRT: Ile149Met, Pro176Arg, Val189Ile e Arg192Lys. These structures increase the important structural information available about the Schistosoma mansoni purine salvage pathway and how it can be selectively private resources.
Pétriacq, Pierre. "Etude de la biosynthese du nad chez les plantes : conséquences physiologiques de sa manipulation chez Arabidopsis thaliana". Thesis, Paris 11, 2011. http://www.theses.fr/2011PA112188/document.
Pełny tekst źródłaPlant development and functions are underpinned by redox reactions which depend on cofactors such as pyridine nucleotides as nicotinamide adenine dinucleotide (NAD). Beside its redox properties, NAD has recently been implicated in cellular signalling. An inducible system based on Escherichia coli quinolinate phosphoribosyltransferase (QPT) overproduction in transgenic Arabidopsis thaliana was set up as a convenient experimental technique to raise NAD content. This build-up highlights the involvement of NAD in plant-pathogen specific defense mechanisms. Furthermore, manipulating endogenous Arabidopsis thaliana QPT levels was used to deregulate NAD production. Such an approach points out the critical role of NAD in C/N interactions by shaking up nitrogen assimilation upon photorespiratory conditions. These results pave the way for a new understanding of signalling mechanisms involving NAD in plants major metabolic functions
Ramakrishnan, Sathiya. "Structural, functional and evolutionary studies on 6-oxopurine phosphoribosyltransferases (PRTases) /". St. Lucia, Qld, 2002. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16106.pdf.
Pełny tekst źródłaNeris, Débora Meira. "Efeito da imunização com enzimas recombinantes do metabolismo de nucleotídeos de Schistosoma mansoni sobre o desenvolvimento da esquistossomose mansônica experimental". Universidade Federal de São Carlos, 2012. https://repositorio.ufscar.br/handle/ufscar/7018.
Pełny tekst źródłaUniversidade Federal de Sao Carlos
Schistosimiasis mansoni is a neglected chronic parasitic disease that affects thousands of people worldwide, caused by the trematode Schistosoma mansoni. In the infected host the disease is characterized by the presence of granuloma, imunnopathological response of the cellular infiltration against egg antigens. Thus, the host-parasite relation favors hepatosplenomegaly, acite and hepatic fibrosis. Current chemotherapy is based on the use of Praziquantel (PZQ), used against all species of Schistosoma spp for over 30 years. The main issue is that the PZQ is practically inactive against immature schistosomula and favors the resistance growth of the existent lineages, which makes the study for new drugs and vaccines that can contribute to the control of this disease even more urgent. One of the paths on the search for new therapeutic targets is the study of essential enzymes to the S. mansoni. In particular, it is known that the enzymes Adenylate Kinase 1 and 2 (ADK), Uridine cytidine Kinase 1 and 2 (UCK), Hypoxanthine guanine phosphoribosyltransferase (HGPRT) e Purine nucleoside phosphorilase 1 (PNP) are found on the metabolic pathways of the parasite s nucleotide, participating in the metabolism of purines and pyrimidines. Our goals in this study were to assess the immunization with these enzymes, using the S. mansoni cercariae infected murine model, and subsequently analyze the acting in oviposition and growth of adult worms. Our results showed that the immunization in Balb/c mice with the UCK enzyme was capable of inducing a specific immune response, which favored a significant reduction of the parasitic load (adult worms). However, it was not possible to observe significant reduction in the number of eliminated eggs. Regarding the immunization with PNP and HGPRT enzymes, the mice had a reduction in the number of eggs per gram of feces. The data obtained are considered interesting and can be new targets for immunotherapy against schistosomiasis mansoni. Thereby, new assays must be made with different dosages of the enzymes for a better assessment on how these enzymes modulate the parasitic load through the eggs reduction, reduction in the adult worms retrieving, as well as the antibody levels during the murine infection by the S.mansoni.
A esquistossomose mansônica é uma doença parasitária, crônica e negligenciada que afeta milhares de pessoas ao redor do mundo, causada pelo trematódeo Schistosoma mansoni. No hospedeiro infectado a doença é caracterizada pela presença do granuloma, resultado imunopatológico do infiltrado celular contra antígenos dos ovos A quimioterapia atual é baseada no uso do Praziquantel (PZQ), usado contra todas as espécies de Schistosoma spp há mais de 30 anos. O principal problema é que o PZQ é praticamente inativo contra esquistossomulos imaturos e favorece o desenvolvimento de resistência das linhagens existentes. Um dos caminhos na busca por novos alvos terapêuticos é o estudo de enzimas que são essenciais para o S. mansoni. Em especial, sabe-se que as enzimas Adenilato Quinase 1 e 2 (ADK), Uridina Citidina Quinase 1 e 2 (UCK), Hipoxantina-guanina fosforibosiltransferase (HGPRT) e Purina Nucleosídeo Fosforilase 1 (PNP) são encontradas nas vias metabólicas de nucleotídeos do parasito, participando do metabolismo de purinas e pirimidinas. A estratégia de utilizar enzimas do parasito na esquistossomose mansônica murina foi de avaliar uma resposta induzida por estas enzimas quando aplicadas em camundongos BALB/c e desafiados com cercarias de S. mansoni. Desta forma, avaliamos a fase crônica de camundongos imunizados e infectados com S. mansoni, onde foram analisadas amostras parasitológicas, hematológicas, sorológicas e fluidos da cavidade peritoneal. Nosso objetivo neste estudo foi avaliar a imunização com essas enzimas, usando o modelo murino infectado com cercarias de S. mansoni e posteriormente avaliar a ação na oviposição e desenvolvimento de vermes adultos. Nossos resultados demonstraram que a imunização em camundongos Balb∕c com a enzima UCK foi capaz de induzir uma resposta imune específica, a qual favoreceu a diminuição significativa da carga parasitária (vermes adultos). No entanto, não foi possível observar redução significativa no número de ovos eliminados. Em relação à imunização com as enzimas PNP e HGPRT os camundongos que receberam as imunizações com PNP e HGPRT tiveram redução no número de ovos por grama de fezes. Os dados obtidos são considerados interessantes e podem ser considerados novos alvos para a imunoterapia contra a esquistosomose mansônica. Dessa forma, novos ensaios deverão ser realizados com diferentes doses das enzimas para melhor avaliar como essas enzimas modulam a carga parasitária através da redução de ovos, diminuição na recuperação de vermes adultos, assim como os níveis de anticorpos durante a infecção murina pelo S. mansoni.
Yu-ChingKo i 柯兪靖. "Nicotinamide Phosphoribosyltransferase (NAMPT) expression in Periodontitis and Peri-implantitis". Thesis, 2016. http://ndltd.ncl.edu.tw/handle/kb99jn.
Pełny tekst źródłaCampbell, Elizabeth. "Nicotinamide phosphoribosyltransferase interaction with polyphenolic modulator in the presence of ATP". Thesis, 2019. https://hdl.handle.net/2144/36172.
Pełny tekst źródłaChen, Shiu-Min, i 陳秀敏. "The study of relationship between hypoxanthine-guanine phosphoribosyltransferase activity and gout or uric acid". Thesis, 2001. http://ndltd.ncl.edu.tw/handle/02530974026597526444.
Pełny tekst źródła高雄醫學大學
公共衛生學研究所
89
Abstract There are two aboriginal tribes (Bunun, Paiwan) and one non-aboriginal tribe (Fukien-Taiwan) included as the study population. The subjects were used to explore the relationship between the activity of hypoxanthine-guanine phosphoribosyltransferase (HPRT) and gout disease or uric acid level. Comparison the difference of HPRT activity between aborigines and non-aborigines and the related factors are the study major aims. A total of 172 samples included in this study. A questionnaire was completed by the subjects to obtain the social demographic data, and a whole blood was drawn to perform the biochemical and HPRT activity analysis. A screening method for detection of HPRT activity in peripheral blood mononuclear cells (PBMCs) was used by high-performance liquid chromatography (HPLC). The results showed that: (1)The mean HPRT activities of subjects with gout and non-gout were 6.76±3.69 nmol/106 cell/h and 7.36±3.50 nmol/106 cell/h, respectively, and they did not make difference in statistics. (2)The mean HPRT activities of subjects aborigines and non-aborigines were 6.90±3.45 nmol/106 cell/h and 7.32±3.85 nmol/106 cell/h, respectively, and they did not different. (3)The mean HPRT activity of women with gout was 5.48±2.89 nmol/106 cell/h that had significant difference to femeal contol was 7.94±3.78 nmol/106 cell/h. (4)The related factors of enzyme activity were amount smoking, history of gout,and triglyceride. The study’s conclusion was the relationship of HPRT activity and gout or uric acid level had not to arrive at significant, and the reason was maybe we could not avoide counfounding of treatment with gouty drug. Key word: HPRT, HPLC, GOUT, URIC ACID
Schwab, Thomas [Verfasser]. "Zusammenhang zwischen Quartärstruktur, Stabilität und katalytischer Aktivität am Beispiel der Anthranilat-Phosphoribosyltransferase / vorgelegt von Thomas Schwab". 2010. http://d-nb.info/1008881627/34.
Pełny tekst źródłaDeuß, Miriam [Verfasser]. "Untersuchungen zur Struktur, Funktion und Dynamik der Anthranilat-Phosphoribosyltransferase aus Sulfolobus solfataricus / vorgelegt von Miriam Deuß". 2007. http://d-nb.info/984762493/34.
Pełny tekst źródłaWang, Chiung-Pei, i 王瓊珮. "Mutation Spectra Induced by Safrole in Hypoxanthine-guanine Phosphoribosyltransferase Locus of Chinese Hamster Ovary K1 Cells". Thesis, 2000. http://ndltd.ncl.edu.tw/handle/93030672516238781842.
Pełny tekst źródła國立陽明大學
藥理學研究所
88
Safrole, an essential oil that has been used in cosmetics and as a food flavoring agents, is classified as a rodent hepatocarcinogen. The carcinogenicity of safrole is mediated through 1'-hydroxysafrole formation, sulfonated to an unstable sulfuric acid ester, and consequently forming stable safrole-DNA adducts. DNA adduct is known to be an initial step of mutagenesis and carcinogenesis. In Taiwan, Piper betle inflorescence contains high concentration of safrole (15 mg/g fresh weight), and may contribute to human exposure (420 microM of safrole in saliva) while chewing betel quid with Piper betle inflorescence. We have documented that safrole has potential to form stable safrole-dG adducts in humans oral cancer tissue following betel quid chewing, which may contribute to oral carcinogenesis. However, the role of safrole-DNA adduct in cancer is not known. To gain insight into the mechanisms of safrole-induced mutations, this study has determined the types and location (spectrum) of mutations induced in the coding region of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene by 1'-hydroxysafrole, the reactive metabolite of safrole. CHO-K1 and HFW cells were exposed to 1'-hydroxysafrole(0~1000 microM) for 24 h. Using 32P-postlabeling technique, this study demonstrated that safrole forms the major premutagenic lesion, N2-(trans-isosafrol-3’-yl)deoxyguanosine. The IC50 of 1'-hydroxysafrole in CHO-K1 and HFW cells were 16.1 and 43.2 microM, respectively. The 1'-hydroxysafrole induced safrole-DNA adduct level is significantly correlated to hprt mutation frequency induced by 1'-hydroxysafrole. hprt mRNA from mutant clones were reverse transcribed to cDNA, amplified by PCR and examined for mutations by DNA sequencing. The result indicated 19/23 safrole-induced mutants contained a single base pair substitution. The majority of the mutations at G: C base pair occurred at sites with G in the nontranscribed strand (16/19). G:C to A:T transitions were the most common type of base pair substitution (9/19). The result reflected the specific types of DNA damage produced by safrole. Results from this study further demonstrated the relationship between safrole-DNA adduct and safrole-induced mutagenesis.
Lorenz, Veronika [Verfasser]. "Komplexe Veränderungen in der Genexpression der Ecto-Nukleosid-5'-Triphosphat-Diphosphohydrolase bei Hypoxanthin-Phosphoribosyltransferase-Defizienz / vorgelegt von Veronika Lorenz". 2009. http://d-nb.info/993681751/34.
Pełny tekst źródłaDo, Hong-Hai, i Erhard Rahm. "Flexible Integration of Molecular-Biological Annotation Data: The GenMapper Approach". 2004. https://ul.qucosa.de/id/qucosa%3A32457.
Pełny tekst źródłaXie, Fu-Bin, i 謝富彬. "Effect of O6-alkylguaninetransferase on the mutational spectrum induced by N-methyl-N?nitro-N-nitrosoguanidine in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase in Chinese hamster ovary cells". Thesis, 1993. http://ndltd.ncl.edu.tw/handle/79164470862931025267.
Pełny tekst źródła